AP
TMO icon

AHL Partners’s Thermo Fisher Scientific TMO Stock Holding History

AHL Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.64M Sell
13,888
-18,728
-57% -$3.59M 0.04% 652
2017
Q3 		$6.17M Buy
32,616
+8,486
+35% +$1.54M 0.11% 327
2017
Q2 		$4.21M Buy
24,130
+17,076
+242% +$2.87M 0.09% 410
2017
Q1 		$1.08M Buy
7,054
+2,777
+65% +$424K 0.02% 769
2016
Q4 		$604K Sell
4,277
-2,173
-34% -$320K 0.02% 781
2016
Q3 		$1.03M Buy
6,450
+1,270
+25% +$196K 0.04% 593
2016
Q2 		$766K Buy
5,180
+1,847
+55% +$273K 0.04% 506
2016
Q1 		$472K Sell
3,333
-15,868
-83% -$2.13M 0.03% 587
2015
Q4 		$2.72M Buy
19,201
+15,578
+430% +$2.08M 0.21% 173
2015
Q3 		$443K Sell
3,623
-36,314
-91% -$4.73M 0.07% 423
2015
Q2 		$5.18M Buy
39,937
+12,975
+48% +$1.69M 0.21% 162
2015
Q1 		$3.62M Buy
26,962
+18,285
+211% +$2.36M 0.14% 307
2014
Q4 		$1.09M Buy
+8,677
New +$1.06M 0.06% 587

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AHL Partners's TMO Position: Q4 2017 in Review

AHL Partners reduced its Thermo Fisher Scientific (TMO) stake by 57% in Q4 2017, selling an estimated $3.59M and leaving 13,888 shares worth $2.64M. The position accounts for 0.04% of the portfolio, ranked #652.

AHL Partners first reported a position in TMO in Q4 2014 and has held it in 13 quarters since. The position peaked at $6.17M in Q3 2017. 1,246 funds tracked by Wall St. Rank hold TMO as of Q4 2017.

  • AHL Partners held 13,888 shares of Thermo Fisher Scientific worth $2.64M as of Q4 2017.
  • AHL Partners sold 18,728 Thermo Fisher Scientific shares in Q4 2017, an estimated $3.59M.
  • Thermo Fisher Scientific made up 0.04% of AHL Partners's portfolio in Q4 2017, its #652 holding.
  • AHL Partners first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 13 quarters since.
  • AHL Partners's Thermo Fisher Scientific position peaked at $6.17M in Q3 2017.
  • 1,246 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.